Main Press Releases

ADA appointed as Kowa Pharmaceutical Asia Pte. Ltd.’s digital agency

ADA wins on the back of their consumer insights and media expertise 

SINGAPORE, 8 JULY 2019ADA, the largest company in Asia that integrates data, insight, media & content to deliver business outcomes, has been appointed by Kowa Pharmaceutical Asia Pte. Ltd. as their regional digital agency.

Kowa Pharmaceutical Asia Pte. Ltd. is a subsidiary of Kowa Company Ltd., a leading Japanese pharmaceuticals company with a global presence. Their key products in South East Asia (SEA) are Q&P Kowa (leading Vitamin Complex Brand in Japan); and Vantelin Kowa (leading Daily Joint Support in Japan).

Vantelin was looking to expand their venture regionally and were looking for an agency partner that had an extensive local knowledge that could support them across SEA. ADA was appointed based on their comprehensive proposal and ability to deliver consumer insights, alongside their creative strength.

ADA’s scope ranges from strategic media consultancy and planning, to creative and data across Singapore, Malaysia, Vietnam, Thailand and Indonesia. Armed with extensive consumer insights from a variety of sources and their proprietary data management platform, Xact, ADA is able to identify consumer patterns and provide recommendations on market potential.

Summer Choo, Country Director, ADA Singapore, said: “We’re delighted to be appointed as Kowa’s digital partner, launching their footprint in South East Asia as the leading Vitamin and Joint Support brand from Japan. Our strength in data mining and analytics has enabled precision in audience targeting; driving better insights for performance marketing. Coupled with efficient creative adaptation, we are able to optimise results effectively from online to offline. Working in tight collaboration with Kowa, we believe the brand will grow in strength across all the markets.”

Nikhil Kapur, Chief Operating Officer – ASEAN, Kowa Pharmaceutical Asia Pte. Ltd., said:

“ADA had won us over with their intensive category insights and their collaborative e-commerce initiatives. With their strong data powered background, they were able to identify new opportunities. We are looking forward to what else ADA has in store for us.”

Kowa Pharmaceutical Asia Pte. Ltd. is a subsidiary of Kowa Company, Ltd. which has grown into a global enterprise with more than a 120-year history since its founding as a cotton fabric wholesaler in Japan in 1894. As the core of the group, Kowa is actively engaging in various business fields including the trading of textiles, machinery, and construction materials, in addition to the manufacturing and sales of medicines, medical equipment, and energy saving products.

 

###

About ADA

ADA, is the largest company in Asia that integrates data, insight, media & content to deliver business outcomes. Part data science, part agency, part consultancy – our eclectic and diverse talent come together to make sure our customers always emerge winners.

ADA is a rebrand of different go-to-market brands (Adparlor, AdReach, Digital Reach). Our shareholders are Axiata Group Berhad and Sumitomo Corporation.

Our business is anchored on 3 main business pillars:

  • Integrated Planning & Delivery (Media Planning, Digital Creatives, Ad Operations, Growth Hacking)
  • Deep Media Integration (Facebook, Google, Telco, AVOD)
  • Merged Analytics (Data Consulting, Data Enrichment, Audience Center)

These pillars are powered by our deep data assets with 280 million unique profiles and >200 raw and derived attributes.

For media enquiries, please contact:
Fiona Ng, Marketing & Communications, ADA
+6 019 257 8277, fiona.ng@ada-asia.com

Leave a Reply

Your email address will not be published. Required fields are marked *